Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

The adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivo.

Harmala LA, Ingulli EG, Curtsinger JM, Lucido MM, Schmidt CS, Weigel BJ, Blazar BR, Mescher MF, Pennell CA.

J Immunol. 2002 Nov 15;169(10):5622-9.

2.

[Development of a novel recombinant BCG for tuberculosis vaccine].

Makino M.

Nihon Hansenbyo Gakkai Zasshi. 2013 Dec;82(3):107-10. Review. Japanese.

PMID:
24579457
3.

VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.

Leblanc P, Moise L, Luza C, Chantaralawan K, Lezeau L, Yuan J, Field M, Richer D, Boyle C, Martin WD, Fishman JB, Berg EA, Baker D, Zeigler B, Mais DE, Taylor W, Coleman R, Warren HS, Gelfand JA, De Groot AS, Brauns T, Poznansky MC.

Hum Vaccin Immunother. 2014;10(10):3022-38. doi: 10.4161/hv.34413. Review.

PMID:
25483693
4.

Fusion proteins with heterologous T helper epitopes. Recombinant E. coli heat-stable enterotoxin proteins.

Löwenadler B, Lycke N.

Int Rev Immunol. 1994;11(2):103-11. Review.

PMID:
7519227
5.

Immune mechanisms in atherosclerosis.

Hansson GK.

Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):1876-90. Review.

6.

T-Cell Therapy: Options for Infectious Diseases.

Parida SK, Poiret T, Zhenjiang L, Meng Q, Heyckendorf J, Lange C, Ambati AS, Rao MV, Valentini D, Ferrara G, Rangelova E, Dodoo E, Zumla A, Maeurer M.

Clin Infect Dis. 2015 Oct 15;61Suppl 3:S217-24. doi: 10.1093/cid/civ615. Review.

Supplemental Content

Support Center